<prompt> All the statements are True regarding Selexipag except?Selective IP receptor antagonistProstacyclin receptor agonistUsed in Pulmonary HypeensionAdverse effects of Selexipag are similar to those of PGI2 analogues  <response>: Selexipag is an orally active, Selective IP receptor agonistProstacyclin Receptor Agonist . Selexipag has shown to reduce Morbidity and Moality in patients with Pulmonary HT . AE : similar to those of PGI2 analogues and include headache, jaw pain, nausea, dizziness, flushing, nasopharyngitis and vomiting. Adverse effects appear to be more common when the drug is taken while fasting . MOA : 